G protein-coupled receptors (GPCRs), crucial for diverse physiological responses, have traditionally been investigated in ...
JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.
Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback